INK Edge

Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following two offers if you want an ad-free experience.

Canadian Insider Club
$229/ year*
Daily Morning INK newsletter
+1 year archive
Canadian Market INK weekly newsletter
+1 year archive
3 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
30-day money back guarantee*
Canadian Insider Ad-Free
$49/ year*
All benefits of basic registration
No 3rd party display ads
30-day money back guarantee*

* Price is subject to applicable taxes. Money back guarantee: For bona fide Ad-Free or Canadian Insider Club subscribers, if you cancel with-in 30 days of first subscribing, we will refund your payment upon request. After cancelling, using the same email that is associated with your account, request a refund via our Contact Us form at the bottom of the page. We will only consider one refund request per household or organization. We cannot accommodate refund requests where an account holder has not provided verifiable address and billing information.

CanniMed Therapeutics (T:CMED) has notable insider buying

Updated Wednesday Dec 06, 2017 02:25 AM EDT

Douglas Banzet, a Director and 10% Holder executive, acquired 12,532 Common Shares on a direct ownership basis at prices ranging from $1.680 and $4.682 through an exercise of options on November 29th, 2017. This represents a $37,063 investment into the company's shares and an account share holdings change of greater than 100%.

CanniMed Therapeutics is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.

CanniMed Therapeutics Inc is a Canada-based plant biopharmaceutical company. It is specialized in the production of pharmaceutical-grade cannabis and offers a range of pharmaceutical-grade cannabis products. In addition, the Company has a plant biotechnology research and product development program focused on the production of plant-based materials for pharmaceutical, agricultural and environmental applications. The Company, through its subsidiary CanniMed Ltd, offers medical cannabis oils, dried medical cannabis, vaporizers, vaporizer parts and accessories. Its CanniMed Oils are made using only dried cannabis flowers. Its vaporizers include Arizer Air vaporizer and Volcano Medic vaporizer. Its vaporizer parts and accessories include ARIZER AIR All Glass Tube (no mouthpiece), ARIZER AIR Charger/Power Adapter, ARIZER AIR Dual Battery Charger, ARIZER AIR Glass Tube with black mouthpiece, ARIZER AIR Replacement Battery, Volcano Medic Air Filter Cap and Volcano Medic Air Filter Set.

INK Edge Outlook

6 months ago
1 year ago
The INK Edge Outlook is a quantitative process that ranks a stock based on our V.I.P. criteria.
View outlooks on all Canadian listed stocks at
Two-week free trial for first time users.
Go to CanniMed Therapeutics Inc. (CMED)'s company page

Comment On!

Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to (via Easy Blurb).

Comment On!

No Comments


Search (past week) for $CMED.CA

  • No tweets found